Tuesday, March 17, 2026

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

BTS’ V Radiates in 2nd Concept Shoot For FRI(END)S

BTS' V, currently serving in the military, radiated a gentle gaze like the spring sunshine.

Tesla’s Stock Plunge Sparks Lawsuit Against CEO Elon Musk

Tesla shareholders have filed a lawsuit alleging insider trading when CEO Elon Musk sold more than $7.5 billion in stock by the end of 2022.

Tag: differential compensation

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.